Idelalisib Completed Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) / Lymphoma, Non-Hodgkin (NHL) / Multiple Myeloma (MM) / Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00710528Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies